Day: June 12, 2023

The 21Shares Lido DAO ETP will provide investors with access to Lido DAO ecosystem ZURICH, June 12, 2023 – 21Shares AG (“21Shares”), the world’s largest issuer of cryptocurrency exchange traded products (ETPs) and a subsidiary of 21.co, today announced the launch of the 21Shares Lido DAO ETP (LIDO). This product offers investors first-of-its-kind single asset exposure to Lido DAO (“Lido”), the market-leading liquid staking solution for various Proof-of-Stake (PoS) blockchains, including Ethereum, Polygon and Solana. Lido’s mission is to make staking simple, secure and decentralized. It does so by enabling users to stake their assets and receive an equal amount of staked tokens (“stTokens”) in return, which accrue staking rewards. These stTokens can then also be traded on the secondary market and used within DeFi applications,...

The Company expands technology for patients with obsessive-compulsive disorder MALVERN, Pa., June 12, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today that they have received 510(k) clearance for their obsessive-compulsive disorder (OCD) Motor Threshold (MT) Cap technology for NeuroStar® Advanced Therapy for Mental Health. “This FDA clearance underscores our commitment to delivering the latest technology that will streamline the treatment process for our customers,” shared Cory Anderson, SVP of R&D and Clinical at Neuronetics. “The unique design and functionality of the OCD MT Cap will enable clinicians to optimize treatment efficiency...

MADRID, Spain, June 12, 2023 (GLOBE NEWSWIRE) — Spanish listed company Lleida.net (OTCQX:LLEIF) (EPA:ALLLN) (BME:LLN), a leader in the registered electronic signature, notification and contracting industry, has reached a significant milestone with the granting of its 301st patent in India, this time for its innovative method of certifying the sending of emails. The patent, numbered 434112 and granted by Intellectual Property India, reinforces the company’s commitment to continue developing disruptive technologies to address the challenges of the digital world in the world’s most populous market. India has 1,428 million inhabitants and a penetration of more than 1.25 billion cell phones, of which more than 850 million are smartphones. Valid until 2033, and under the title “METHOD FOR CERTIFYING THE SENDING OF ELECTRONIC...

ATLANTA, June 12, 2023 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company” or “Cumulus”) today announced the preliminary results of its “modified Dutch auction” tender offer, which expired at midnight, New York City time, at the end of the day on June 9, 2023. Based on the preliminary count by Continental Stock Transfer & Trust Company, the depositary for the tender offer, a total of 1,745,005 shares of the Company’s Class A common stock were validly tendered at or below a purchase price $3.25 per share and not validly withdrawn, including 5,000 shares of the Company’s Class A common stock that were tendered through notice of guaranteed delivery. In accordance with the terms and conditions of the tender offer and based on the preliminary count by the depositary, the Company expects...

Company’s priority oncology clinical programs continue to advance toward key milestones Additional clinical trial site now open at University of Nebraska for Phase 2 study of Ampligen® for the treatment of pancreatic cancer (AMP-270) Ongoing progress toward Phase 1 data in clinical development program of Ampligen for the treatment of early-stage triple negative breast cancer Significant findings from a new analysis support the potential to identify patients with LAPC that could respond better to Ampligen Company bolsters patent portfolio for Ampligen as a potential therapy against Ebola virus disease OCALA, Fla., June 12, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers,...

SALT LAKE CITY / UTAH , June 12, 2023 (GLOBE NEWSWIRE) — omniQ Corp. (NASDAQ: OMQS), an object identification company providing Artificial Intelligence (AI)-based technology solutions CEO Shai Lustgarten sits down with Robert Kraft, CEO of Planet Microcap to discuss the power of Machine Vision and the opportunity ahead. Links below: YouTube: https://www.youtube.com/watch?v=kmb7JSkA7Xo Apple: https://podcasts.apple.com/us/podcast/omniq-corp-nasdaq-omqs-creates-automation-through-object/id1024217659?i=1000616242494 Spotify: https://open.spotify.com/episode/2mtW1Ke2kZOQKGLya5S6RI Podbean: https://planetmicrocap.podbean.com/e/omniq-corp-nasdaq-omqs-creates-automation-through-object-identification/ Substack: https://microcapnewsletter.substack.com/p/omniq-corp-nasdaq-omqs-creates-automation#details About omniQ: OMNIQ Corp. provides...

VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) will host its 2022 Annual General and Special Meeting of Shareholders (the “Meeting”) on Friday, June 23, 2023, at 2:00 pm PT / 5:00 pm ET. B2Gold is pleased to announce the support of Institutional Shareholder Services (“ISS”), who has recommended that shareholders vote FOR all proposed items to be considered at the upcoming Meeting. The Meeting will be held at the Fairmont Hotel Vancouver, Pacific Ballroom, 900 West Georgia Street, Vancouver, BC, Canada, V6C 2W6, and in a virtual format conducted via live audio webcast online. The Meeting will be available to registered and non-registered shareholders and guests, and accessible via live webcast by clicking here: https://web.lumiagm.com/485739236. B2Gold...

MB-106 continues to demonstrate favorable safety and efficacy profile Overall response rate of 83% in cohort with durable responses observed; one patient remains in complete remission at 22 months All patients were refractory to BTK inhibitors, and no patients have started new anti-WM treatment after MB-106 Currently no FDA-approved CAR T treatments for WM WORCESTER, Mass., June 12, 2023 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced that updated data from the ongoing Phase 1/2 clinical trial of MB-106, a CD20-targeted, autologous CAR T cell therapy, show a favorable safety and efficacy...

Virtual presentation on Thursday, June 15, 2023, at 1:45 PM ET NEW YORK, June 12, 2023 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with over $4 billion in retail sales generated by its brands through livestreaming alone and over 10,000 hours of show programming time, today announced that it will be presenting and hosting one-on-one meetings at the Sidoti & Company Small-Cap Virtual Investor Conference on Wednesday, June 14 and Thursday, June 15. Robert W. D’Loren, Chairman and Chief Executive Officer of Xcel Brands, will be leading the formal presentation and answering questions from investors on Thursday, June 15 at 1:45 p.m. ET. Xcel Brands will provide an overview on its growth opportunities and business transformation, including the recent 25-year...